Edition:
United States

People: Omnicell Inc (OMCL.O)

OMCL.O on Nasdaq

43.20USD
21 Jul 2017
Change (% chg)

$0.05 (+0.12%)
Prev Close
$43.15
Open
$43.45
Day's High
$43.80
Day's Low
$42.85
Volume
136,045
Avg. Vol
219,350
52-wk High
$44.60
52-wk Low
$30.35

Seim, Robin 

Mr. Robin Gene Seim is Executive Vice President, Global Automation and Medication Adherence of the Company. He joined Omnicell in February 2006 as Vice President and was named Chief Financial Officer in March 2006. In January 2009, Mr. Seim was named Chief Financial Officer and Vice President Finance, Administration and Manufacturing. In March 2012, Mr. Seim was named Chief Financial Officer and Executive Vice President Finance, Administration and Manufacturing. In February 2015, Mr. Seim was named Chief Financial Officer and Executive Vice President, Finance, International and Manufacturing. In January 2016, Mr. Seim was named Executive Vice President, Global Automation and Medication Adherence. In March 2016, Mr. Seim was named President, Global Automation and Medication Adherence. Prior to joining Omnicell, Mr. Seim served as Chief Financial Officer of several technology companies, including Villa Montage Systems, Inc. from 1999 to 2001, Candera, Inc. from 2001 to 2004 and Mirra, Inc., in 2005. Prior to 1999, Mr. Seim held a number of management positions with Nortel Networks, Bay Networks, and IBM. Mr. Seim received a B.S. in accounting from California State University, Sacramento.

Basic Compensation

Total Annual Compensation, USD 581,586
Restricted Stock Awards, USD 366,093
Long-Term Incentive Plans, USD --
All Other, USD 221,409
Fiscal Year Total, USD 1,169,090

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Randall Lipps

4,065,190

Peter Kuipers

914,239

Daniel Johnston

1,025,250

J. Christopher Drew

1,157,540

Nhat Ngo

1,450,230

Robin Seim

1,169,090
As Of  30 Dec 2016